Electronic-Nutrition-Optimizer for Personalized Prevention
- Conditions
- DiabetesFrailtyCardiovascular DiseasesHypertensionDementia
- Registration Number
- NCT04866264
- Lead Sponsor
- Heike Bischoff-Ferrari
- Brief Summary
This study aims to develop and validate a tool for immediate nutrition assessment and to test its user feasibility in routine clinical practice for health promotion.
- Detailed Description
Small changes in diet have been shown to have an important impact on health and the risk of age-related chronic diseases, such as cardiovascular disease, diabetes, frailty and dementia. However, this knowledge has not yet been implemented into routine clinical practice, because practical tools that allow a comprehensive nutrition assessment in the clinical care setting are missing. In addition, doctors are generally not educated in giving nutritional advice to patients. In this pilot project, we aim to push forward and enable the potential of nutrition as a core primary prevention strategy for people at risk of developing chronic diseases. This will be achieved by using, as a stepping stone, the electronic 216-food-item food frequency questionnaire which was developed for the European DO-HEALTH study and was tested in over 2000 adults. The investigators want to extend this tool to not only capture the personal dietary intake, but also to produce an immediate report, comparing the personal diet to the Mediterranean and MIND diet patterns and providing a patient's intake of protein and other nutrients. The report will additionally indicate the patient's diet-related, personalized risks of cardio-vascular disease, diabetes, frailty and cognitive decline, and recommend dietary changes to reduce these risks.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 88
- Stable inpatients from the Department of heart surgery, or Center for senior trauma patient at the university hospital Zurich (inpatient group)
- Ambulatory volunteers who can visit the center for aging and mobility (CAM) independently ("outpatients" group)
- ≥50 years
- If already involved in another ongoing interventional clinical trial, except an interaction with this intervention can be excluded
- People with an impaired short-term memory (MMSE <24)
- Patients following a specific diet recommended by a medical professional, due to diseases such as diabetes, chronic diseases of the gastrointestinal tract, severe kidney disease, or patients allergic to the main components of the Mediterranean diet/MINDdiet (olive oil, nuts)
- Outpatients: HbA1C ≥6.5% Inpatients: HbA1C ≥6.5% or diagnosed diabetes mellitus if HbA1C is not available in KISIM
- BMI > 30 kg/m2
- Individuals per se not willing to change diet
- Instable clinical conditions (e.g. acute infection) at enrolment
- Patients with active cancer (except non-melanoma skin cancer) or current cancer treatment or any other advanced severe disease
- Living in a nursing home and/or receiving prepared meals (i.e. usually not eating home cooked meals)
- Inability to read and or speak German necessary to understand the instructions
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Primary Outcome Measures
Name Time Method Perception questionnaire using system usability scale Baseline Feasibility Study (in- and outpatient group) Scale from 1 to 5, indicating 1 "not true", 5 "very true"
Subjective effectiveness questionnaire of eNutrition Optimizer month 3 to 6 Feasibility Study (in- and outpatient group) Scale from 1 to 5, indicating 1 "not true", 5 "very true"
- Secondary Outcome Measures
Name Time Method waist-to-hip ratio 6 months Change in diet (outpatient group) and safety (outpatient group)
blood marker Non-HDL cholesterol (mmol/l) 6 months Validation Study (outpatient group)
blood marker Folate (µg/l) 6 months Validation Study (outpatient group)
blood marker Iron (µmol/l) 6 months Validation Study (outpatient group)
blood marker Soluble transferrin receptor (mg/l) 6 months Validation Study (outpatient group)
blood marker Vitamin B12 (ng/l) 6 months Validation Study (outpatient group)
blood marker Ferritin (µg/l) 6 months Validation Study (outpatient group)
24h diet recalls month 4 to 6 Validation Study (outpatient group)
blood marker Triglycerides (mmol/l) 6 months Validation Study (outpatient group)
blood marker Fasting glucose (mmol/l) 6 months Validation Study (outpatient group)
blood marker Interleukin-6 (pg/ml) 6 months Validation Study (outpatient group)
Dietary patterns assessed with the eNutrition Optimizer (based on a food frequency questionnaire), MIND diet score ranging from 0 to 15 with 0=worst, 15=best ; Med Diet score ranging from 0 to 55 with 0=worst, 15=best 6 months Change in diet (outpatient group)
blood marker HDL cholesterol (mmol/l) 6 months Validation Study (outpatient group)
blood marker Transferrin (µmol/l) 6 months Validation Study (outpatient group)
blood marker high sensitive-CRP (mg/l) 6 months Validation Study (outpatient group)
BMI 6 months Change in diet (outpatient group) and safety (outpatient group)
systolic and diastolic blood pressure 6 months Change in diet (outpatient group)
blood marker HbA1C (%) 6 months Validation Study (outpatient group)
Trial Locations
- Locations (1)
Centre on Aging and Mobility, University of Zurich
🇨🇭Zurich, ZH, Switzerland
Centre on Aging and Mobility, University of Zurich🇨🇭Zurich, ZH, Switzerland